Recce Pharmaceuticals Ltd.ASX: RCE

Patient Dosing Complete in Phase II ABSSSI Trial of R327G

Jan 21, 2025 at 4:18 AM UTC · Issued by Recce Pharmaceuticals Ltd.

Recce Ltd has released a press release.

View Attachment